Structures by: Krautscheid H.
Total: 336
C36H30Cl3NOP2V
C36H30Cl3NOP2V
Zeitschrift fuer Anorganische und Allgemeine Chemie (1993) 619, 1023-1026
a=10.18(1)Å b=18.26(2)Å c=18.59(2)Å
α=90° β=93.65(9)° γ=90°
C18H48B3I3N3P3
C18H48B3I3N3P3
Zeitschrift fuer Anorganische und Allgemeine Chemie (1998) 624, 7 1105-1110
a=22.786(2)Å b=19.874(2)Å c=14.373(1)Å
α=90° β=97.67(1)° γ=90°
C18H49B3I2N3P3
C18H49B3I2N3P3
Zeitschrift fuer Anorganische und Allgemeine Chemie (1998) 624, 7 1105-1110
a=17.690(2)Å b=7.9335(7)Å c=22.382(3)Å
α=90° β=90.671(16)° γ=90°
C22H54B3I3N5P3
C22H54B3I3N5P3
Zeitschrift fuer Anorganische und Allgemeine Chemie (1998) 624, 7 1105-1110
a=12.546(4)Å b=14.113(5)Å c=20.899(9)Å
α=90° β=90° γ=90°
((C H3)4 N) (Sn I3)
C4H12I3NSn
Zeitschrift fuer Anorganische und Allgemeine Chemie (2001) 627, 841-846
a=9.738Å b=9.738Å c=7.887Å
α=90° β=90° γ=120°
[Bu3N(CH2)4NBu3]4[Pb7I22]
[Bu3N(CH2)4NBu3]4[Pb7I22]
Journal of the Chemical Society, Dalton Transactions (1999) 16 2731
a=16.730(2)Å b=26.823(3)Å c=20.496(2)Å
α=90.00° β=105.870(10)° γ=90.00°
[Bu3N(CH2)4NBu3]4[Pb10I28]
[Bu3N(CH2)4NBu3]4[Pb10I28]
Journal of the Chemical Society, Dalton Transactions (1999) 16 2731
a=22.9116(9)Å b=22.9116(9)Å c=18.5203(7)Å
α=90.00° β=90.00° γ=90.00°
[Bu3N(CH2)4NBu3]2[Pb3I10]*DMF*0.5Et2O
[Bu3N(CH2)4NBu3]2[Pb3I10]*DMF*0.5Et2O
Journal of the Chemical Society, Dalton Transactions (1999) 16 2731
a=15.3391(9)Å b=16.9204(10)Å c=20.6738(14)Å
α=72.963(5)° β=70.719(5)° γ=74.467(4)°
[Me3N(CH2)5NMe3]2[Pb3I10]
[Me3N(CH2)5NMe3]2[Pb3I10]
Journal of the Chemical Society, Dalton Transactions (1999) 16 2731
a=20.889(2)Å b=13.2764(10)Å c=18.4226(17)Å
α=90.00° β=101.245(10)° γ=90.00°
[Pr3N(CH2)5NPr3]2[Pb7I18]
[Pr3N(CH2)5NPr3]2[Pb7I18]
Journal of the Chemical Society, Dalton Transactions (1999) 16 2731
a=11.9140(10)Å b=28.112(4)Å c=15.368(2)Å
α=90.00° β=110.248(9)° γ=90.00°
C11H10CuN3S
C11H10CuN3S
Journal of the Chemical Society, Dalton Transactions (1998) 18 3071
a=5.850(3)Å b=14.076(6)Å c=14.792(8)Å
α=90.00° β=94.80(4)° γ=90.00°
C6H5AgN2S
C6H5AgN2S
Journal of the Chemical Society, Dalton Transactions (1998) 18 3071
a=4.0221(5)Å b=10.9748(12)Å c=17.809(2)Å
α=90.00° β=90.00° γ=90.00°
C11H10AgN3S
C11H10AgN3S
Journal of the Chemical Society, Dalton Transactions (1998) 18 3071
a=7.772(2)Å b=17.084(4)Å c=18.495(4)Å
α=90.00° β=90.00° γ=90.00°
C22H20AgCuN6S2
C22H20AgCuN6S2
Journal of the Chemical Society, Dalton Transactions (1998) 18 3071
a=14.3250(7)Å b=10.9567(5)Å c=17.1474(7)Å
α=90.00° β=110.686(4)° γ=90.00°
C18H15Ag2CuN6S3
C18H15Ag2CuN6S3
Journal of the Chemical Society, Dalton Transactions (1998) 18 3071
a=8.9808(6)Å b=15.0009(10)Å c=8.4219(6)Å
α=90.00° β=92.288(6)° γ=90.00°
Molybdenum(VI) oxide 2:1 complex with 1,2-bis(1,2,4-triazol-4- yl)ethane
C12H16Mo4N12O12
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=15.2779(16)Å b=12.6491(13)Å c=12.1712(11)Å
α=90.00° β=90.00° γ=90.00°
Molybdenum(VI) oxide 2:1 complex with 1,3-bis(1,2,4-triazol-4- yl)propane
C7H10Mo2N6O6
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=9.4050(4)Å b=11.7467(5)Å c=11.9594(5)Å
α=90.00° β=90.00° γ=90.00°
Molybdenum(VI) oxide 2:1 complex with trans-1,4-bis(1,2,4- triazol-4-yl)cyclohexane
C10H14Mo2N6O6
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=12.0221(7)Å b=13.0629(8)Å c=19.4476(16)Å
α=90.00° β=90.00° γ=90.00°
Molybdenum(VI) oxide 2:1 complex with 1,3-bis(1,2,4-triazol-4- yl)adamantane Hexahydrate
C14H18Mo2N6O6,6(H2O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=15.1155(9)Å b=12.4471(7)Å c=12.4209(9)Å
α=90.00° β=90.00° γ=90.00°
Molybdenum(VI) oxide 2:1 complex with 4,9-bis(1,2,4-triazol-4- yl)diamantane Semihydrate
C18H22Mo2N6O6,0.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=12.4256(9)Å b=16.6809(16)Å c=10.4993(10)Å
α=90.00° β=90.00° γ=90.00°
Molybdenum(VI) oxide 4:1 complex with 1,6-bis(1,2,4-triazol-4- yl)diamantane Dihydrate
C18H22N6,4(MoO3),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=7.3804(8)Å b=7.5670(10)Å c=11.5827(14)Å
α=85.928(12)° β=86.074(10)° γ=89.873(11)°
Molybdenum(VI) oxide complex with 5-(4-(1,2,4-triazol-4- yl)phenyl)tetrazole
C9H7MoN7O3
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=19.5123(11)Å b=19.5123(11)Å c=11.9438(7)Å
α=90.00° β=90.00° γ=90.00°
3-Nitro-4,4'-bipyrazole
C6H5N5O2
New Journal of Chemistry (2018)
a=5.4831(2)Å b=5.4831(2)Å c=47.463(3)Å
α=90° β=90° γ=90°
3,3',5,5'-Tetranitro-4,4'-bipyrazole
C6H2N8O8
New Journal of Chemistry (2018)
a=16.4281(13)Å b=16.4281(13)Å c=8.3705(6)Å
α=90° β=90° γ=90°
3,5-Dinitro-4,4'-bipyrazole
C6H4N6O4
New Journal of Chemistry (2018)
a=6.1653(7)Å b=15.7789(12)Å c=8.7387(10)Å
α=90° β=107.434(10)° γ=90°
3,3',5,5'-Tetranitro-4,4'-bipyrazole Hydrate
C6H2N8O8,H2O
New Journal of Chemistry (2018)
a=11.1017(9)Å b=13.9227(10)Å c=8.2166(8)Å
α=90° β=110.654(10)° γ=90°
Copper(I) Tetrafluoroborate 4:5 complex with 1,4-bi(pyridazin-4-yl)benzene, solvate with 4 Chloroform
C74H54B4Cl12Cu4F16N20
New Journal of Chemistry (2008) 32, 11 1910
a=12.5703(9)Å b=13.7895(13)Å c=14.1629(12)Å
α=94.203(11)° β=93.205(11)° γ=107.835(10)°
Copper(I) Dithionate bis(Acetonitrile) complex with 1,4-bi(pyridazin-4-yl)benzene
C18H16Cu2N6O6S2
New Journal of Chemistry (2008) 32, 11 1910
a=9.3471(6)Å b=18.9283(11)Å c=12.4791(9)Å
α=90.00° β=101.718(8)° γ=90.00°
Silver(I) nitrate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Chloroform solvate
C15H11AgCl3N5O3
New Journal of Chemistry (2008) 32, 11 1910
a=8.3964(2)Å b=9.5399(2)Å c=12.4383(3)Å
α=80.0473(10)° β=82.901(2)° γ=64.9520(11)°
Silver(I) Pentafluoropropionate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene
C17H10AgF5N4O2
New Journal of Chemistry (2008) 32, 11 1910
a=5.5566(7)Å b=10.5875(13)Å c=15.419(2)Å
α=72.987(10)° β=84.721(11)° γ=82.058(11)°
Silver(I) Trifluoroacetate 4:3 complex with 1,4-bi(pyridazin-4-yl)benzene, Acetonitrile solvate
C52H33Ag4F12N13O8
New Journal of Chemistry (2008) 32, 11 1910
a=10.9059(10)Å b=11.1531(11)Å c=13.8012(13)Å
α=92.620(11)° β=108.916(11)° γ=117.522(10)°
Silver(I) Methanesulfonate 4:3 complex with 1,4-bi(pyridazin-4-yl)benzene, solvate with 2 Chloroform
C48H44Ag4Cl6N12O12S4
New Journal of Chemistry (2008) 32, 11 1910
a=19.3101(19)Å b=17.3714(15)Å c=18.1903(15)Å
α=90.00° β=99.346(5)° γ=90.00°
Silver(I) Isophthalate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Hydrate
C66H62Ag6N12O22
New Journal of Chemistry (2008) 32, 11 1910
a=9.4238(6)Å b=14.2038(12)Å c=14.2032(10)Å
α=104.457(8)° β=98.140(8)° γ=108.924(9)°
C16H10CuN4O4
C16H10CuN4O4
CrystEngComm (2019) 21, 43 6523
a=13.5518(4)Å b=13.9161(4)Å c=14.8283(4)Å
α=90° β=90.716(3)° γ=90°
C16H12CuN4O5
C16H12CuN4O5
CrystEngComm (2019) 21, 43 6523
a=14.251(2)Å b=13.399(2)Å c=14.6369(19)Å
α=90° β=93.001(11)° γ=90°
C33H24Cu2N8O9
C33H24Cu2N8O9
CrystEngComm (2019) 21, 43 6523
a=13.7136(4)Å b=13.2270(5)Å c=15.1795(5)Å
α=90° β=93.415(3)° γ=90°
C16H12CuN4O5
C16H12CuN4O5
CrystEngComm (2019) 21, 43 6523
a=13.8663(4)Å b=13.2350(4)Å c=15.0241(4)Å
α=90° β=93.199(2)° γ=90°
C32H20Cu2N8O10
C32H20Cu2N8O10
CrystEngComm (2019) 21, 43 6523
a=14.5493(3)Å b=11.93948(14)Å c=14.1517(3)Å
α=90° β=93.6939(5)° γ=90°
C38H40NNdO10
C38H40NNdO10
Chemical communications (Cambridge, England) (2010) 46, 32 5948-5950
a=15.944(3)Å b=17.819(4)Å c=12.906(3)Å
α=90.00° β=93.01(3)° γ=90.00°
C36H33N4O8Tb,C3H7NO
C36H33N4O8Tb,C3H7NO
Chemical communications (Cambridge, England) (2010) 46, 32 5948-5950
a=9.774(2)Å b=10.682(2)Å c=19.281(4)Å
α=91.16(3)° β=101.99(3)° γ=95.68(3)°
C36H33N4NdO8,C3H7NO
C36H33N4NdO8,C3H7NO
Chemical communications (Cambridge, England) (2010) 46, 32 5948-5950
a=9.8275(6)Å b=10.7284(7)Å c=19.2871(12)Å
α=91.021(5)° β=102.172(5)° γ=95.652(5)°
Copper(ii) Fluorophosphate 1:3 Complex with 1,4-bi(1,2,4- triazol-4-yl)benzene
C30H24CuN18,(FO3P)
CrystEngComm (2008) 10, 9 1216
a=16.0657(11)Å b=16.0657(11)Å c=7.7720(4)Å
α=90.00° β=90.00° γ=120.00°
Copper(ii) Nitrate 2:5 Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Dihydrate
C50H40Cu2N30,4(NO3),2(H2O)
CrystEngComm (2008) 10, 9 1216
a=24.6600(18)Å b=15.8459(8)Å c=7.7808(5)Å
α=90.00° β=95.485(8)° γ=90.00°
Copper(ii) Chloride 1:2 Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Dodecahydrate
C20H40Cl2CuN12O12
CrystEngComm (2008) 10, 9 1216
a=28.331(3)Å b=16.1470(12)Å c=7.1760(9)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Bromide 1:2 Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Dodecahydrate
(C20H16BrCuN12),Br,12(H2O)
CrystEngComm (2008) 10, 9 1216
a=28.449(3)Å b=15.7732(17)Å c=7.2593(7)Å
α=90.00° β=90.00° γ=90.00°
Dihydroxo Tetracopper(ii) Triflate Complex with 1,4-bi(1,2,4- triazol-4-yl)benzene, Dodecahydrate
C56H66Cu4F18N30O32S6
CrystEngComm (2008) 10, 9 1216
a=13.3427(11)Å b=13.4047(12)Å c=13.5620(12)Å
α=102.339(2)° β=104.3690(10)° γ=90.4770(10)°
Copper(ii) Sulfate Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Hexahydrate
C10H20CuN6O10S
CrystEngComm (2008) 10, 9 1216
a=7.1442(4)Å b=19.4387(15)Å c=17.3114(12)Å
α=90.00° β=90.00° γ=90.00°
Tris(5-(4-(1,2,4-triazol-4-yl)phenyl)tetrazolato) dicopper(ii) Chloride, Dodecahydrate
C27H42ClCu2N21O12
CrystEngComm (2008) 10, 9 1216
a=25.822(2)Å b=7.7119(7)Å c=25.1892(19)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate 4:5 Complex with Pyridazino(4,5- d)pyridazine
(C30H20Ag4N20),4(ClO4)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=17.0076(10)Å b=17.0076(10)Å c=7.8591(5)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Trifluorometanesulfonate Complex with Pyridazino(4,5-d)pyridazine, Solvate with 0.33 Water
C18H14Ag3N12O,3(CF3O3S)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=15.6887(9)Å b=15.6887(9)Å c=24.4805(18)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Hexaflurosilicate Tetrafluoroborate Complex with Pyridazino(4,5-d)pyridazine Hydrate
2(C15H10Ag2N10),F6Si,2(BF4),4(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=17.0801(11)Å b=17.0782(11)Å c=7.5920(7)Å
α=90.00° β=90.00° γ=90.00°
Bis(mu-3-hydroxotricopper(ii)) heptakis(4,4'-bi(1,2,4- triazole)) Decabromide Hexahydrate
C28H42Br10Cu6N42O8
Dalton transactions (Cambridge, England : 2003) (2006) 31 3772-3776
a=11.9996(11)Å b=21.0665(17)Å c=15.6477(17)Å
α=90.00° β=109.555(11)° γ=90.00°
Bis(mu-3-hydroxotricopper(ii)) heptakis(4,4'-bi(1,2,4- triazole)) Decahloride Octahydrate
C28H46Cl10Cu6N42O10
Dalton transactions (Cambridge, England : 2003) (2006) 31 3772-3776
a=21.3590(19)Å b=12.0195(8)Å c=28.954(2)Å
α=90.00° β=97.896(10)° γ=90.00°
Hexachloro Dihydroxo Tetraaqua mu-3-Hydroxotricopper(ii) mu-3- Oxotricopper(ii) Complex with 4,4'-(1,2,4-bitriazole), Chloride Semihydrate
C12H24Cl7Cu6N18O8.5
Dalton transactions (Cambridge, England : 2003) (2006) 31 3772-3776
a=30.0968(12)Å b=30.0968(12)Å c=30.0968(12)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Nitrate complex with 1,2,4,5-tetrazine
(C2H2N4),Ag,(NO3)
Dalton Transactions (2009) 15 2856-2864
a=7.7351(7)Å b=10.8172(8)Å c=7.1540(6)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate complex with 1,2,4,5-tetrazine
(C2H2N4),Ag,(ClO4)
Dalton Transactions (2009) 15 2856-2864
a=8.4650(7)Å b=10.4250(11)Å c=7.7750(6)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Nitrate 2:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine
(C4H6N4),2Ag,2(NO3)
Dalton Transactions (2009) 15 2856-2864
a=9.0359(8)Å b=13.2071(13)Å c=8.7513(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate 2:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine, Dihydrate
(C4H6N4),2Ag,2(ClO4),2(H2O)
Dalton Transactions (2009) 15 2856-2864
a=6.7481(8)Å b=7.9981(9)Å c=8.1382(10)Å
α=65.302(11)° β=65.663(10)° γ=66.151(11)°
Copper(i) chloride 4:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine
C4H6N4,4(CuCl)
Dalton Transactions (2009) 15 2856-2864
a=6.8143(9)Å b=6.2582(8)Å c=13.6220(17)Å
α=90.00° β=98.907(4)° γ=90.00°
Silver(i) Triflate 3:1 complex with 2,6-dimethyl-1,2,4,5- tetrazine, dihydrate
2(C4H6N4),6Ag,6(CF3O3S),4(H2O)
Dalton Transactions (2009) 15 2856-2864
a=10.5847(9)Å b=19.0579(13)Å c=23.1327(14)Å
α=90.00° β=102.038(10)° γ=90.00°
Copper(ii) acetate 2:1 complex with 4,4'-Bipyridazine, Dihydrate
C8H9CuN2O4,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=7.4144(9)Å b=8.2275(9)Å c=10.9023(13)Å
α=76.965(14)° β=82.505(13)° γ=63.267(13)°
Zinc(ii) Nitrate 1:1 Complex with 4,4'-Bipyridazine
C8H6N6O6Zn
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.07500(10)Å b=16.9431(3)Å c=11.9592(2)Å
α=90.00° β=101.3800(10)° γ=90.00°
Copper(ii) Dithionate 1:2 Complex with 4,4'-Bipyridazine, Dihydrate
C16H16CuN8O2,O6S2
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=15.1065(13)Å b=11.8885(9)Å c=11.0631(10)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Trifluoroacetate 2:3 Complex with 4,4'-Bipyridazine
C32H18CU2F12N12O8
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=10.4940(6)Å b=10.9798(8)Å c=18.3058(13)Å
α=90.00° β=98.572(5)° γ=90.00°
Copper(ii) Tetrafluoroborate 1:2 Complex with 4,4'- Bipyridazine, Solvate with 3.33 Water
C48H36Cu3N24O4,6(BF4),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=12.0861(8)Å b=14.6555(8)Å c=21.5673(15)Å
α=90.00° β=104.025(8)° γ=90.00°
Dihydroxotricopper(ii) Trifluoroacetate Complex with 4,4'- Bipyridazine, Tetrahydrate
(C28H24Cu3F6N12O8),2(C2F3O2),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=15.4234(9)Å b=15.7761(12)Å c=19.1034(12)Å
α=90.00° β=108.591(6)° γ=90.00°
Copper(i) Chloride 2:1 Complex with 4,4'-Bipyridazine
C8H6CL2CU2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.617(2)Å b=13.132(4)Å c=6.642(2)Å
α=90.00° β=114.23(2)° γ=90.00°
Copper(i) Bromide 2:1 Complex with 4,4'-Bipyridazine
C8H6Br2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.712(2)Å b=13.450(4)Å c=6.807(3)Å
α=90.00° β=112.79(3)° γ=90.00°
Copper(i) Iodide 2:1 Complex with 4,4'-Bipyridazine
C8H6Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=10.1405(5)Å b=10.1405(5)Å c=11.9784(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Hexafluorosilicate 2:3 Complex with Pyridazino(4,5- d)pyridazine, Decahydrate
C18H20Ag4N12O4,2(F6Si),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=8.85070(10)Å b=17.2093(3)Å c=12.0859(2)Å
α=90.00° β=100.7850(10)° γ=90.00°
Silver(i) Trifluoroacetate Complex with Pyridazino(4,5- d)pyridazine
C8H4AgF3N4O2
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=7.3514(2)Å b=12.5897(3)Å c=11.3054(3)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Pentafluoropropionate 2:1 Complex with Pyridazino(4,5-d)pyridazine
C12H4Ag2F10N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=25.2810(10)Å b=25.2810(10)Å c=7.4007(4)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Hexafluorosilicate 2:3 Complex with 4,4'- Bipyridazine, Trihydrate
C24H22Ag4N12O2,2(F6Si),H2O
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=7.7384(2)Å b=38.1690(8)Å c=50.8067(10)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Tetrafluoroborate 4:3 Complex with 4,4'- Bipyridazine Hydrate
(C24H18Ag4N12),4(BF4),(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=10.6823(8)Å b=12.1323(7)Å c=14.6844(9)Å
α=90.00° β=97.017(8)° γ=90.00°
Silver(i) Trifluoromethylsulfonate Complex with 4,4'- Bipyridazine, Solvate with 2/3 Water
C24H20Ag3N12O,3(CF3O3S),H2O
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=8.7652(6)Å b=22.1004(15)Å c=10.4417(7)Å
α=90.00° β=91.8740(10)° γ=90.00°
Silver(i) Heptafluorobutyrate 2:1 Complex with 4,4'- Bipyridazine
C16H6Ag2F14N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=28.4273(11)Å b=28.4273(11)Å c=7.5353(3)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Pentafluoropropionate 2:1 Complex with 4,4'- Bipyridazine
C14H6Ag2F10N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=26.9862(12)Å b=26.9862(12)Å c=7.6176(4)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Trifluoroacetate 2:1 Complex with 4,4'- Bipyridazine, Solvate with 2/7 Chloroform
C84H42Ag14F42N28O28,2(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=13.9023(2)Å b=14.4405(3)Å c=18.2666(2)Å
α=107.0790(10)° β=111.5920(10)° γ=94.2320(10)°
C6H5CuN2S
C6H5CuN2S
Journal of the Chemical Society, Dalton Transactions (1998) 18 3071
a=17.435(9)Å b=3.855(2)Å c=11.159(6)Å
α=90.00° β=107.55(2)° γ=90.00°
C17H15AgCuN5S2
C17H15AgCuN5S2
Journal of the Chemical Society, Dalton Transactions (1998) 18 3071
a=52.305(4)Å b=12.088(1)Å c=12.785(1)Å
α=90.00° β=90.00° γ=90.00°
3,3'-Dinitro-4,4'-bipyrazole
C6H4N6O4
New Journal of Chemistry (2018)
a=15.9744(9)Å b=6.5428(8)Å c=8.9414(8)Å
α=90° β=118.739(10)° γ=90°
3,5,3'-Trinitro-4,4'-bipyrazole
C6H3N7O6
New Journal of Chemistry (2018)
a=8.6064(8)Å b=11.9636(9)Å c=10.1200(9)Å
α=90° β=114.148(10)° γ=90°
Silver(I) Benzoate 2:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Hydrate
C28H24Ag2N4O6
New Journal of Chemistry (2008) 32, 11 1910
a=7.2863(3)Å b=14.3867(6)Å c=12.2774(5)Å
α=90.00° β=90.945(3)° γ=90.00°
[Zn4O{(Metrz-pba)2mPh}3]-8DMF
C78H54N18O13Zn4,8(C3H7NO)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 3 817-824
a=18.9863(11)Å b=18.9863(11)Å c=18.0965(10)Å
α=90.00° β=90.00° γ=120.00°
[Zn4O{(Metrz-pba)2mPh}3]
C78H54N18O13Zn4
Dalton transactions (Cambridge, England : 2003) (2012) 41, 3 817-824
a=19.2401(8)Å b=19.2401(8)Å c=17.8208(9)Å
α=90.00° β=90.00° γ=120.00°
Copper(i) Bromide 2:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline, dichloromethane solvate
C13H14Br2Cl2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=17.7304(19)Å b=17.7304(19)Å c=12.6008(11)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Iodide 2:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline
C12H12Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=12.3475(10)Å b=12.3475(10)Å c=13.2122(12)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Bromide 2:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline
C12H12Br2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=12.3176(11)Å b=12.3176(11)Å c=12.772(2)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Iodide 2:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline, chloroform solvate
C13H13Cl3Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=17.614(2)Å b=17.614(2)Å c=13.136(2)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Iodide 3:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline, acetonitrile solvate
C80H84Cu18I18N28
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=20.463(2)Å b=20.463(2)Å c=17.989(2)Å
α=90.00° β=90.00° γ=120.00°
Copper(i) Iodide 2:1 Complex with 2,2,7,7-Tetramethyl- 1,2,3,6,7,8-Hexahydro-cinnolino(5,4,3-cde)cinnoline, dichloromethane solvate
C17H22Cl2Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=26.1899(14)Å b=26.1899(14)Å c=9.6096(10)Å
α=90.00° β=90.00° γ=120.00°
Copper(i) Iodide 2:1 Complex with 2,2,7,7-Tetramethyl- 1,2,3,6,7,8-Hexahydro-cinnolino(5,4,3-cde)cinnoline, acetonitrile solvate
C18H23Cu2I2N5
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=24.063(3)Å b=13.5575(16)Å c=6.8122(8)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Bromide 4:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline, acetonitrile solvate
C16H18Cu4I4N6
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=7.6797(9)Å b=7.7125(9)Å c=11.3151(10)Å
α=104.415(2)° β=104.170(2)° γ=96.141(2)°
Bis(μ~2~-ethane-1,2-disulfido)-tetrakis(triisopropylphosphine)-tetra-copper
C40H92Cu4P4S4
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8635-8642
a=11.4153(6)Å b=21.1400(10)Å c=11.0770(6)Å
α=90.00° β=100.105(5)° γ=90.00°
Bis(μ~2~-ethane-1,2-disulfido)-bis(triisopropylphosphine)-tetramethyl-di-copper-di-gallium
C26H62Cu2Ga2P2S4
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8635-8642
a=17.4373(11)Å b=15.7295(7)Å c=15.3649(10)Å
α=90.00° β=116.444(5)° γ=90.00°
Bis(μ~2~-ethane-1,2-disulfido)-bis(triisopropylphosphine)-bis(phenylsulfido)-dimethyl-di-copper-di-gallium tetrahydrofuran solvate
C36H66Cu2Ga2P2S6,2(C4H8O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8635-8642
a=10.5998(10)Å b=11.5070(11)Å c=13.6932(15)Å
α=67.290(7)° β=72.432(8)° γ=65.161(7)°
Bis-[1,3-di(1,2,4-triazol-4-yl)adamantane]diaquacadmium(II) Tetrabromocadmate(II) Dihydrate
C56H80Cd2N24O4,2(Br4Cd),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=14.7635(12)Å b=29.457(3)Å c=17.5708(16)Å
α=90.00° β=90.031(8)° γ=90.00°
Bis-(1,3,5-tri(1,2,4-triazol-4-yl)adamantane)cadmium(ii) Nitrate Hexahydrate
(C32H38CdN18),2(NO3),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=11.5603(2)Å b=11.5603(2)Å c=53.0233(19)Å
α=90.00° β=90.00° γ=120.00°
Tetrakis-[1,3-di(1,2,4-triazol-4-yl)adamantane]cadmium(II) bis-triiodocadmate(II) Tetrahydrate
C56H72Cd3I6N24,4(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=10.3397(2)Å b=11.3871(2)Å c=17.8908(5)Å
α=95.6320(10)° β=102.9610(10)° γ=115.4300(10)°
Bis-(1,3-di(1,2,4-triazol-4-yl)adamantane)disilver(i) dinitrate Dihydrate
C28H36Ag2N12,2(NO3),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8675-8689
a=6.5192(6)Å b=15.4818(11)Å c=16.9913(12)Å
α=89.230(9)° β=84.607(10)° γ=85.574(9)°